|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Analyst Conference Summaries |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Bristol-Myers Squibb
|
2023 | |||
Bristol-Myers Squibb Q4 2022 |
Bristol-Myers Squibb Q1 2023 |
||
Feb. 4, 2023 | April 27, 2023 | ||
2022 | |||
Bristol-Myers Squibb Q4 2021 |
Bristol-Myers Squibb Q1 2022 |
Bristol-Myers Squibb Q2 2022 |
Bristol-Myers Squibb Q3 2022 |
Feb. 4, 2022 | April 29, 2022 | July 27, 2022 | Oct. 26, 2022 |
2021 | |||
Bristol-Myers Squibb Q4 2020 |
Bristol-Myers Squibb Q1 2021 |
Bristol-Myers Squibb Q2 2021 |
Bristol-Myers Squibb Q3 2021 |
Feb. 4, 2021 | April 29, 2021 | July 28, 2021 | Oct. 27, 2021 |
2020 | |||
Bristol-Myers Squibb Q4 2019 |
Bristol-Myers Squibb Q1 2020 |
Bristol-Myers Squibb Q2 2020 |
Bristol-Myers Squibb Q3 2020 |
Feb. 6, 2020 | May 7, 2020 | Aug. 6, 2020 | Nov. 5, 2020 |
2019 | |||
Bristol-Myers Squibb Q4 2018 |
Bristol-Myers Squibb Q1 2019 |
Bristol-Myers Squibb Q2 2019 |
Bristol-Myers Squibb Q3 2019 |
Jan. 24, 2019 | April 25, 2019 | July 25, 2019 | Oct. 31, 2019 |
Bristol-Myers Squibb (BMY) is a large-cap biotechnology and pharmaceutical company.
More Analyst Conference Pages:
AGEN |
AGIO |
ALNY |
AMAT |
AMGN |
APRE |
ARWR |
BIIB |
BMY |
CDTX |
CLDX |
FATE |
GILD |
GLYC |
ILMN |
INO |
IONS |
MCHP |
MRNA |
PLX |
REGN |
RNA |
SAGE |
SGEN |
VRTX |
VSTM |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2023 William P. Meyers